FDA Drug Application (205649) for XIGDUO XR by ASTRAZENECA AB

Back to FDA Applications sponsored by ASTRAZENECA AB

Application Number205649
Product Number001
FormTABLET, EXTENDED RELEASE;ORAL
DosageEQ 5MG BASE;500MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameXIGDUO XR
Active IngredientDAPAGLIFLOZIN PROPANEDIOL; METFORMIN HYDROCHLORIDE



Back to FDA Applications sponsored by ASTRAZENECA AB

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.